1. Home
  2. GBIO vs ANGH Comparison

GBIO vs ANGH Comparison

Compare GBIO & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • ANGH
  • Stock Information
  • Founded
  • GBIO 2016
  • ANGH 2012
  • Country
  • GBIO United States
  • ANGH United Arab Emirates
  • Employees
  • GBIO N/A
  • ANGH N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • ANGH Telecommunications Equipment
  • Sector
  • GBIO Health Care
  • ANGH Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • ANGH Nasdaq
  • Market Cap
  • GBIO 29.5M
  • ANGH 32.1M
  • IPO Year
  • GBIO 2020
  • ANGH N/A
  • Fundamental
  • Price
  • GBIO $5.99
  • ANGH $3.14
  • Analyst Decision
  • GBIO Buy
  • ANGH
  • Analyst Count
  • GBIO 4
  • ANGH 0
  • Target Price
  • GBIO $10.67
  • ANGH N/A
  • AVG Volume (30 Days)
  • GBIO 70.7K
  • ANGH 13.1K
  • Earning Date
  • GBIO 11-05-2025
  • ANGH 09-30-2025
  • Dividend Yield
  • GBIO N/A
  • ANGH N/A
  • EPS Growth
  • GBIO N/A
  • ANGH N/A
  • EPS
  • GBIO N/A
  • ANGH N/A
  • Revenue
  • GBIO $21,230,000.00
  • ANGH $78,093,405.00
  • Revenue This Year
  • GBIO N/A
  • ANGH N/A
  • Revenue Next Year
  • GBIO N/A
  • ANGH N/A
  • P/E Ratio
  • GBIO N/A
  • ANGH N/A
  • Revenue Growth
  • GBIO 61.15
  • ANGH 88.72
  • 52 Week Low
  • GBIO $3.00
  • ANGH $2.53
  • 52 Week High
  • GBIO $29.10
  • ANGH $9.40
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 54.23
  • ANGH 42.05
  • Support Level
  • GBIO $5.51
  • ANGH $3.14
  • Resistance Level
  • GBIO $6.04
  • ANGH $3.40
  • Average True Range (ATR)
  • GBIO 0.32
  • ANGH 0.26
  • MACD
  • GBIO -0.08
  • ANGH 0.04
  • Stochastic Oscillator
  • GBIO 64.86
  • ANGH 45.07

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.

Share on Social Networks: